Ignite Creation Date:
2025-12-25 @ 2:13 AM
Ignite Modification Date:
2025-12-26 @ 12:42 AM
Study NCT ID:
NCT05375760
Status:
TERMINATED
Last Update Posted:
2024-10-23
First Post:
2022-05-16
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Randomized, Open-label, Dose-ranging Study in Adults and Pediatric Individuals ≥ 12 Years of Age to Assess the Safety, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of AZD7442, for Pre-exposure Prophylaxis of COVID-19
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-06-09
Start Date Type:
ACTUAL
Primary Completion Date:
2023-10-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-10-04
Completion Date Type:
ACTUAL
First Submit Date:
2022-05-16
First Submit QC Date:
None
Study First Post Date:
2022-05-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-07-10
Results First Submit QC Date:
None
Results First Post Date:
2024-10-23
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-30
Last Update Post Date:
2024-10-23
Last Update Post Date Type:
ACTUAL